BTVPUR

RSS

inactivated vaccine against bluetongue virus serotypes 1 and 8

Authorised
This medicine is authorised for use in the European Union.

Overview

BTVPUR is a vaccine used in sheep and cattle to protect them against bluetongue disease, an infection caused by the bluetongue virus which is transmitted by midges. The vaccine is used to prevent viraemia (the presence of viruses in the blood) and reduce the signs of the disease.

The vaccine contains inactivated (killed) bluetongue virus. The variety (serotype) of the virus in the vaccine is selected depending on which serotypes are circulating and causing disease at the time of manufacture, so it may contain serotype 1, 2, 4 or 8 or a combination of any two of these.

This EPAR was last updated on 27/10/2020

Authorisation details

Product details
Name
BTVPUR
Agency product number
EMEA/V/C/002231
Active substance
  • bluetongue-virus serotype-1 antigen
  • bluetongue virus serotype 8 antigen
International non-proprietary name (INN) or common name
inactivated vaccine against bluetongue virus serotypes 1 and 8
Species
  • Sheep
  • Cattle
Anatomical therapeutic chemical veterinary (ATCvet) codes
  • QI04AA02
  • QI02AA08
Publication details
Marketing-authorisation holder
Boehringer Ingelheim Vetmedica GmbH
Revision
12
Date of issue of marketing authorisation valid throughout the European Union
17/12/2010
Contact address

55216 Ingelheim am Rhein
Germany

Product information

14/10/2020 BTVPUR - EMEA/V/C/002231 - IG/1296

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Immunologicals

Therapeutic indication

Sheep
Active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/ or 8 (combination of maximum 2 serotypes), active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1,2, 4 and/ or 8 (combination of maximum 2 serotypes), active immunisation of sheep to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/or 8 (combination of maximum 2 serotypes).

Cattle
Active immunisation of cattle to prevent viraemia caused by bluetongue virus serotype 1, 2, 4 and/ or 8, and to reduce clinical signs caused by bluetongue virus serotypes when observed in this species: serotype 1, 4 and / or 8 (combination of maximum 2 serotypes).
Active immunisation of cattle to prevent viraemia caused by bluetongue virus serotype 1, 2, 4 and/ or 8, and to reduce clinical signs caused by bluetongue virus serotypes when observed in this species: serotype 1, 4 and / or 8 (combination of maximum 2 serotypes).

Active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/or 8 (combination of maximum 2 serotypes).

Assessment history

News

How useful was this page?

Add your rating